5PSQ-221 Safety profile of experimental therapies used in the COVID-19 pandemic based on data from the National Minimum Data Set

Background and importanceIn response to the COVID-19 pandemic, scientific societies and regulatory agencies quickly reviewed any available evidence to fill the therapeutic gap. In this context, many drugs were used with an uncertain benefit–risk profile that needs to be evaluated.Aim and objectivesT...

Full description

Bibliographic Details

Published in:	European journal of hospital pharmacy. Science and practice Vol. 28; no. Suppl 1; p. A163
Main Authors:	Oterino Moreira, I, Sanz Marquez, S, Carrasco Piernavieja, L, Zhan Zhou, E, Martinez Simón, JJ, Salvador Llana, I, Lorenzo Martínez, S, Morales Catalan, MDC, Plo Seco, I, Roldan Navarro, P, Pérez Encinas, M
Format:	Journal Article
Language:	English
Published:	London BMJ Publishing Group LTD 01-03-2021
Subjects:	Conflicts of interest Coronaviruses COVID-19 Pandemics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!